NCT06852365 2026-02-19
COR-PCOS
University of Pennsylvania
Phase 2 Recruiting
Clinical Trials
15 trialsNCT06005558 2024-07-05
Low Dose Versus High Dose Methylene Blue in Septic Patients
National Cancer Institute, Egypt
Phase 2/3 Completed
NCT03954366 2023-06-08
Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives
pharmaand GmbH
Phase 1 Completed
NCT03197077 2023-04-07
Elonva_IVM
Universitair Ziekenhuis Brussel
Phase 3 Completed
NCT05340634 2022-04-28
Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.
Margan Biotech
Phase 4 Completed
NCT02705963 2022-02-09
A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors
Novartis
Phase 1 Completed
NCT03843736 2019-10-10
The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.
Peking Union Medical College Hospital
Phase 3 Unknown
NCT02744131 2018-02-05
OCP
Kar Clinic & Hospital Pvt. Ltd.
Phase NA Unknown
NCT00704912 2016-11-07
OWL-PCOS
Milton S. Hershey Medical Center
Phase 2 Completed
NCT00283816 2015-05-15
Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy
University of Rochester
Phase 3 Completed
NCT01798875 2013-03-01
PCOS, Therapy and Markers of Cardiovascular Risk
Medical University of Gdansk
Phase 4 Unknown
NCT01014507 2012-06-25
PROFE
University of Cologne
Phase 2 Completed
NCT01372293 2011-09-12
17b-ACO
Federal University of Rio Grande do Sul
Phase NA Completed
NCT00842140 2010-07-22
Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women
University of Sao Paulo
Phase NA Completed
NCT00948402 2009-10-14
PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives
Federico II University
Phase 3 Completed